TAGS: Natural-based Adhesives
LaunchPad Medical, Inc. has received U.S. Food and Drug Administration’s approval to initiate a clinical study to examine the safety and efficacy of the company’s bone adhesive biomaterial Tetranite®.
Uses of Tetranite®
The adhesive is used for immediate stabilization of dental implants for tooth extractions.
The use of Tetranite® will allow for the immediate placement of implants and, in many cases, obviate a costly, complex, and lengthy bone grafting process, greatly accelerating the overall treatment timeframe for many patients.
LaunchPad Medical's Chief Executive Officer, Brian Hess said: that they will be commercializing the bone
adhesive technology to improve and accelerate the current treatment paradigm for dental implant procedures.
The company has also received investigational review board (IRB) approval.
These approvals mark a significant milestone since it is the first-in-man trial based on this technology platform.
Unique Properties of Tetranite®
-
Immediate fixation of fractured bone fragments
-
Stabilization of metal implants to bone
-
Non-toxic and effective way of repairing bone fractures and defects
-
Securing implant devices
-
Act as a Scaffold to facilitate bone growth by getting resorbed and replaced by the new bone during the natural process of bone remodeling
LaunchPad Medical's Tetranite® technology has not yet been approved for commercial use.
Source: LaunchPad Medical